Virtus Biotech Clinical Trials ETF
 
 
 
 
基本資料
種類: ETF
費用比率%: 0.79
資產淨值: 42.98
成立日期: 16/12/2014
 
分析
市值分佈:
27.79%
大市值
37.89%
中市值
34.65%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 07/11/2026 05:47) 總持有投資項目: 132  
0%
 
100%
     10大 (16.14%)
代號 名稱 佔比% ▼ 持有日期
BCYCBicycle Therapeutics plc0.7030/10/2026
QUREuniQure NV0.7030/10/2026
CLYMClimb Bio Inc0.7030/10/2026
RCKTRocket Pharmaceuticals0.6930/10/2026
ASMBAssembly Biosciences0.6830/10/2026
SLDBSolid Biosciences0.6730/10/2026
IMVTImmunovant0.6730/10/2026
ANABAnaptysBio0.6730/10/2026
ANNXAnnexon0.6730/10/2026
CRVSCorvus Pharmaceuticals0.6530/10/2026
STOKStoke Therapeutics0.6330/09/2026
PROKProKidney Corp0.6130/10/2026
ALTAltimmune0.6130/10/2026
TYRATyra Biosciences0.6130/10/2026
CELCCelcuity0.6130/10/2026
INBXInhibrx Biosciences Inc.0.6030/10/2026
CTMXCytomX Therapeutics0.6030/10/2026
MLYSMineralys Therapeutics0.6030/10/2026
IMTXImmatics NV0.6030/10/2026
RCUSArcus Biosciences0.5930/10/2026
  1    2    3    4   5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.